Santa Clara, CA: Mylan has agreed to pay $465 million to settle fraud claims that it underpaid rebates for the EpiPen, which amounts to stealing from the government federal authorities claimed. The lawsuit, alleging violations of the False Claims Act, was possible due to Sanofi acting as a [Original Article]
